In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

P&G gets dermatology rights to Curis's technology

Executive Summary

Curis (pathways for cell repair and regeneration) has granted Procter & Gamble Pharmaceuticals an exclusive worldwide, royalty-bearing license to use its hedgehog agonist technology in developing topical, non-systemic dermatology drugs. P&G will first evaluate and develop hair-growth regulation and in the future may develop therapeutics for skin disorders.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Topical Delivery
Deal Status
  • Terminated
Deal Type
  • Alliance
    • R&D and Marketing (Licensing)

Related Companies